éclateral

What éclateral does

éclateral is a Bristol, UK-based private limited company founded in 2021 that develops a digitalised home diagnostic platform called o~pal. The system comprises three integrated components: a Bluetooth-enabled handheld reader, a companion mobile application, and disposable test cassettes. The proprietary technology — a granted patent co-invented by CSO Dr. Uroš Zupančič — overlays a bespoke electrochemical element onto conventional lateral flow strips from any manufacturer, enabling quantitative digital readouts rather than visual interpretation, with results delivered to the user's smartphone in approximately thirty minutes. Use cases highlighted by the company include remote diagnosis and patient monitoring for healthcare professionals, women's health and fertility/menopause tracking, tropical disease screening in underserved populations, and double-blinded clinical trial deployments.

The commercial model is hardware-plus-consumable: the o~pal reader is sold as a reusable device (marketed as capable of supporting 5,000+ tests) with ongoing revenue from disposable test cassettes, distributed direct-to-consumer via letterbox delivery and supplemented by an enterprise channel serving healthcare professionals and clinical trial sponsors. The company emphasises low-cost positioning ('the most affordable lateral flow test reader available'), accessibility features (audio readout, password-secured app, anonymous clinician sharing), and sustainability alignment with five UN SDG themes. Revenue, funding, and customer figures are not publicly disclosed; ISO 13485 certification is in progress, CB/EN electrical safety compliance is in place, and the company is registered with the UK ICO for GDPR purposes.

The company is founder-led by Dr. Paul Ko Ferrigno (CEO, previously founder of Aptuscan acquired by Avacta Group in 2012) and Dr. Uroš Zupančič (CSO, formerly of Harvard Wyss Institute and Novartis). It operates from a single site at Future Space on the University of West of England campus, runs a 1–10 person team, has no disclosed institutional investors, and lists no named customers in the available data.

Name

éclateral

Legal name

éclateral Limited

Website

https://eclateral.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

éclateral is a Bristol, UK startup that sells the o~pal system — a Bluetooth reader, mobile app, and electrochemical lateral flow test cassettes — delivering quantified home diagnostic results in 30 minutes to consumers, healthcare professionals, and clinical trial sponsors.

Ownership category

akta.pro rank

Product category

Home Diagnostic Testing

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

akta.pro secondary industries

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK), Home Diagnostic & Self-Test OTC Kits (HLAIADAO)

Keywords

• Lateral flow diagnostics
• Home health testing
• Electrochemical biosensors
• Point-of-care diagnostics
• Rapid diagnostic devices

Headquarters

HQ city

Bristol

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. o~pal Reader Device Sales: Sale of the o~pal handheld reader device - a lightweight portable Bluetooth-enabled device for reading test strips.
2. o~pal Test Cassettes (Consumables): Disposable lateral flow test cassettes compatible with the o~pal reader. Each device has capacity for over 5,000 tests using éclateral home-health test options.
3. Test Certificate Services: Contracted partner provides test certificates following analysis, shared with users via contact details provided.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels2 records

Core offering

éclateral develops and sells the o~pal system — a Bluetooth-enabled handheld reader device paired with a mobile app and disposable test cassettes that use patented electrochemical technology overlaid on lateral flow strips to deliver clinical-grade diagnostic results directly to a user's smartphone in approximately 30 minutes for at-home use.

Product overview

éclateral offers the o~pal diagnostic system—a single unified product consisting of three integrated components: the o~pal reader (a Bluetooth-enabled handheld device), the o~pal mobile app (for result display and tracking), and o~pal test cassettes (electrochemical lateral flow tests). The system works as a complete home-health testing solution where the reader reads test cassettes and transmits results via Bluetooth to the companion app on the user's smartphone.

Differentiator

Problem solved

Functional benefit

Brands

• o~pal: A portable handheld device for rapid health testing, disease detection, and preventative screening. The o~pal reader uses Bluetooth connectivity to pair with smart mobile devices and delivers test results in approximately thirty minutes through a mobile app.

Products and services

• o~pal Diagnostic System A low-cost, clinical-grade home health and wellness testing system for individual consumers. The integrated solution combines a Bluetooth handheld reader, mobile app, and compatible electrochemical lateral flow cassettes to deliver rapid diagnostic results to a smartphone in approximately 30 minutes.
• o~pal Reader Device A portable, lightweight, Bluetooth-enabled handheld reader that reads electrochemical test strips and sends results to the o~pal mobile app. Designed for reuse up to 5,000 times with éclateral home-health test options.
• o~pal Mobile App A companion mobile application for iOS and Android that pairs with the o~pal reader via Bluetooth, displays clear positive/negative results, tracks test history over time, reads results aloud for accessibility, and enables optional sharing with healthcare professionals.
• o~pal Test Cassettes Disposable lateral flow test cassettes compatible with the o~pal reader that use a novel electrochemical reading element to detect a range of viruses and medical conditions, providing quantified results beyond visual-only readouts.

Quantifiable outcome

• Each device has capacity for over 5,000 tests
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Suppliers and Manufacturers (Unnamed)minorOthersActively seeking partnerships with suppliers and manufacturers who share commitment to sustainability and have implemented measures to reduce their carbon footprint. Unnamed partners for sustainable packaging alternatives.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• LumiraDx: LumiraDx built a connected point-of-care diagnostic reader plus consumable test strips sold to healthcare professionals and consumers - the closest direct analogue to éclateral's o~pal reusable reader + disposable electrochemical lateral flow cassettes model.
• CUE Health: CUE Health developed a connected, Bluetooth-enabled home diagnostic reader that pairs with a mobile app to deliver rapid results - a near-identical product architecture and DTC-plus-clinical positioning to éclateral's o~pal system.
• Abingdon Health: Abingdon Health is a UK-based lateral flow diagnostics developer and contract manufacturer with a similar core technology focus on lateral flow immunoassays, making it a direct technology peer for éclateral's electrochemical LFT work.

Emerging players

• Mologic: Mologic is a UK rapid diagnostics company developing lateral flow and point-of-care tests including consumer/self-test formats - overlapping with éclateral's home-use POCT positioning and serving similar tropical-disease and global-health use cases.
• Healthy.io: Healthy.io turns smartphone cameras into clinical-grade home diagnostic readers (e.g. urinalysis), sharing éclateral's smartphone-paired, at-home, consumer health-testing thesis and remote patient monitoring angle.
• Thriva: Thriva is a UK-based direct-to-consumer home health testing company (blood-based panels delivered by post) - a comparable DTC home-diagnostic brand and channel even though it uses邮寄 lab testing rather than a connected reader.
• LetsGetChecked: LetsGetChecked is a direct-to-consumer at-home diagnostics company selling mail-in test kits with digital results and clinician follow-up - a comparable DTC home-testing brand even though its model is lab-based rather than a connected reader.

Broad incumbents

• Abbott: Abbott (BinaxNOW, Panbio, etc.) is the dominant incumbent in lateral flow rapid diagnostics globally, defining the visual-readout standard that éclateral's electrochemical quantified reader aims to disrupt.
• Roche Diagnostics: Roche operates a broad diagnostics portfolio including established lateral flow rapid tests and high-throughput immunoassays - a large incumbent whose scale and clinical relationships could outcompete a small UK reader startup.
• QuidelOrtho: QuidelOrtho (Sofia platform, Triage, QuickVue) is a major lateral flow and rapid diagnostics incumbent serving clinical and OTC channels - the kind of established player that sets pricing and distribution expectations in the same market as éclateral.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/in/paul-ko-ferrigno-3b3696a

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about éclateral